There is one question that matters more than any other in facial fat grafting, and it is the question most consultations skate past: how much of the fat actually stays?
Everything else follows from that. The before-and-after photograph, the recovery timeline, the decision about whether to do this at all: all of it hinges on what proportion of the transferred fat establishes a blood supply and becomes permanent, and what proportion is quietly resorbed over the first several months. Nearly every technical decision in this operation exists to move that number in one direction.
Dr. Hardik Doshi, a double board certified facial plastic surgeon serving Long Island and New York City, has watched the conversation around facial volume shift substantially. Patients arrive with what he describes as filler fatigue. They have spent years adding more product, syringe after syringe, and at some point the mirror stopped rewarding them for it. The face became heavier without becoming younger. What those patients want now is different: reposition the tissue that has descended, and restore the volume that was lost using their own fat rather than a manufactured gel. That is a more surgical way of thinking about aging, and it is a more durable one.
This guide is built around survival because survival is the spine of the entire procedure. Harvest technique affects it. Processing affects it. The size of the fat parcels affects it. The depth and the layering of the injection affect it. The blood supply of the recipient bed affects it. Smoking affects it. Weight fluctuation affects it. Understanding those variables is the difference between a result that looks like you at a better decade and a result that looks lumpy, overfilled, or simply gone by spring.
What Facial Fat Transfer Actually Involves
Facial fat grafting is a three-part operation, and each part is a separate opportunity to protect or destroy the graft.
The first part is harvest. Fat is taken, usually from the lower abdomen, the flanks, or the medial thigh, through a small access incision using a blunt cannula attached to a syringe. This is not liposuction in the body contouring sense. The suction pressure is deliberately low, the cannula ports are small, and the goal is intact adipocytes rather than maximum volume removed. A full face rarely needs more than 30 to 60 mL of processed fat.
The second part is processing. The aspirate that comes out of the donor site is not pure fat. It contains tumescent fluid, local anesthetic, blood, oil from ruptured cells, and connective tissue debris. All of it has to be separated out, because injecting free oil and blood into the face produces inflammation, and inflammation produces resorption and occasionally nodules. Processing methods include gravity decanting, low-speed centrifugation, closed washing and filtration systems, and mesh straining. What they share is the goal of delivering a graft that is mostly intact fat cells and stromal tissue.
The third part is placement, and this is where the surgeon's judgment matters most. Fat is injected through blunt microcannulas in small aliquots, laid down in threads on withdrawal rather than deposited in boluses, across multiple tissue planes and multiple passes. The face is filled the way a sculptor builds up clay, not the way a syringe fills a balloon.
The whole thing is typically performed under intravenous sedation or general anesthesia, often at the same time as a lifting procedure, though a standalone facial fat transfer can be done under local anesthesia with oral sedation in carefully selected patients.
The Survival Question: How Much Fat Actually Stays
Here is the honest answer. Published retention figures for facial fat grafting span roughly 30 to 80 percent, and the range is that wide because the variables are that numerous. In well selected patients with good technique and a well vascularized recipient bed, the commonly cited working expectation is that somewhere between 50 and 70 percent of the transferred volume persists long term. Some regions of the face do better than that. Some do considerably worse.
That is not a hedge. It is the state of the evidence, and any surgeon quoting a single crisp percentage for every patient and every facial subunit is simplifying something that does not simplify.
What happens to the fat that does not survive is worth understanding, because it explains the recovery timeline. A fat graft has no blood supply of its own for the first two to three days. It survives on plasmatic imbibition, meaning nutrients diffuse to it from the surrounding tissue fluid. Diffusion works over a distance of roughly 1.5 to 2 millimeters. Any adipocyte sitting further than that from a vascularized surface is going to die, no matter how skilled the surgeon or how healthy the patient.
This single fact explains nearly the entire technique. Neovascularization, the ingrowth of new capillaries into the graft, begins around day three and continues through the first two to three weeks. Graft remodeling continues for months. By the three month mark the volume is broadly settled. By six months it is settled with confidence. Whatever is present at six months has a blood supply, and fat with a blood supply behaves like any other fat in your body: it stays, it ages with you, and it responds to your weight.
That is the sense in which facial fat transfer is permanent. The surviving graft is permanent tissue. It is not, however, a freeze frame. The face continues to age around it, the skeleton continues to remodel, and the ligaments continue to relax.
Micro Fat, Nano Fat, and Traditional Macro Fat
The most useful technical framework for facial fat grafting is parcel size. How finely the fat is processed determines how large the individual clusters of cells are, which determines how deep they can be placed, which determines what they can accomplish.
Macro fat: structural volume in the deep planes
Macro fat is the coarsest preparation, harvested and delivered through larger bore cannulas, with fat parcels in the range of roughly 2 to 3 millimeters. It carries the most intact adipose architecture and is the workhorse for deep structural volume. It goes into the deep medial cheek compartment, along the pyriform aperture beside the nose, into the deep temporal fossa beneath the temporalis fascia, and along the prejowl sulcus at the mandibular border.
These are supraperiosteal and deep fat compartment targets: layers with generous blood supply, minimal motion, and enough thickness to hide a larger parcel. Placed there, macro fat rebuilds the skeletal scaffolding that erodes with age. Placed superficially, the same parcel size produces visible irregularity, because a 3 millimeter lump sitting under thin skin is a 3 millimeter lump you can see in raking light.
Micro fat: the everyday currency of facial grafting
Micro fat is harvested through smaller multiport cannulas, typically in the 1 to 2 millimeter range, and processed to smaller parcels. It is the preparation most facial surgeons use for most of the face. It can be layered in the subcutaneous plane, in the intermediate fat compartments, and along transitions where the deep fat has to blend into thinner tissue: the lid cheek junction, the nasolabial fold shoulder, the lateral brow, the temples, the chin, the perioral region.
Micro fat grafting has a structural survival advantage built into its geometry. Smaller parcels mean a higher surface area to volume ratio, which means more of the graft sits within diffusion distance of a vascularized surface during the critical first days. That is why fine, threaded, multi-pass placement of small parcels tends to outperform a single large bolus, even when the total volume delivered is identical.
Nano fat: not volume at all
Nano fat is a different animal, and patients frequently misunderstand it. Nano fat is produced by mechanically emulsifying processed fat, shuttling it repeatedly between syringes through progressively smaller connectors and then filtering it. The process deliberately destroys the mature adipocytes. What survives is a stromal vascular fraction rich in adipose derived stem cells, growth factors, and regenerative elements.
Nano fat therefore provides essentially no volume. It should never be sold as a filler. Its purpose is tissue quality: skin thickness, dermal collagen, fine crepey texture, dark discoloration in the tear trough region, early perioral rhytids, and the dull thin skin that no amount of volume correction will fix. It is delivered intradermally or in the immediate subdermal plane through very fine cannulas or needles, sometimes in combination with microneedling.
The practical point is that nano fat and micro fat solve different problems and are often used in the same operation. Structural volume goes deep. Regenerative fat goes shallow. Dr. Doshi has written previously about how micro and nano fat advance fat transfer beyond the older single technique model, and the combination is now standard in sophisticated facial practice.
How Harvest Technique Changes Survival
Adipocytes are fragile cells. They rupture under shear stress, under excessive negative pressure, and under mechanical handling. Much of the variation in graft survival between surgeons is decided before a single drop of fat reaches the face.
Low negative pressure matters. Harvesting by hand with a syringe, or with a machine set to low vacuum, preserves cell membrane integrity far better than high pressure suction. Cannula design matters: multiport blunt cannulas with small side ports produce parcels of a consistent size without the crush injury of aggressive scraping.
Donor site selection matters less than patients expect. The lower abdomen and inner thigh are commonly favored, but the way the fat is taken matters more than where it is taken from.
Tumescent technique matters. Adequate infiltration with dilute epinephrine reduces bleeding and blood contamination of the graft, and blood in the graft is pro-inflammatory. At the same time, the graft must not be left sitting in lidocaine for an extended period, because local anesthetic is toxic to adipocytes over time.
The interval between harvest and injection should also be short, because fat left on the back table degrades.
Processing: Removing What Poisons the Graft
The aspirate arrives contaminated, and every contaminant has a specific cost.
Free oil, released from ruptured adipocytes, is intensely inflammatory and is associated with oil cysts and nodule formation. Blood delivers inflammatory mediators to a graft already fighting for oxygen. Tumescent fluid dilutes the graft, so the syringe volume overstates the true fat volume and the surgeon undercorrects without realizing it. Fibrous debris obstructs fine cannulas and forces higher injection pressure.
Centrifugation at low force separates the aspirate into three layers: oil on top, concentrated fat in the middle, and aqueous fluid with blood below. The middle layer is the graft, and excessive force damages cells, so gentle protocols are preferred. Closed washing and filtration systems achieve a similar separation with less handling and air exposure.
No single processing method has proven decisively superior for facial grafting. What consistently matters is that processing is gentle, closed, fast, and thorough.
Injection Depth, Layering, and Why Boluses Fail
If there is one technical principle that predicts a good fat transfer result, it is this: small volumes, many passes, multiple planes, always on withdrawal.
A single 1 mL bolus placed in one spot creates a sphere. The cells at the center of that sphere are more than 2 millimeters from any vascularized surface, and they die. The dead center of the sphere becomes an oil cyst or a firm nodule, and the patient loses both volume and smoothness. The same 1 mL delivered in fifty passes of 0.02 mL each, fanned across three planes, creates fifty thin threads, each one surrounded by recipient tissue on all sides. Nearly all of it is within diffusion distance.
Layering also produces a better aesthetic result independent of survival. Deep supraperiosteal fat restores projection and skeletal contour. Intermediate compartment placement restores the light reflecting convexities of youth. Subcutaneous micro fat smooths transitions. Intradermal nano fat improves the surface. A face built in four layers looks integrated; a face built in one looks inflated.
Injection pressure is part of the same picture. Fine cannulas and 1 mL syringes give tactile control and limit the force applied to the graft.
Recipient Site Blood Supply: Why Some Areas Take Better Than Others
Graft survival is not uniform across the face, and the differences are predictable.
Well vascularized, relatively immobile recipient beds do best. The deep medial cheek, the temples beneath the fascia, the lateral cheek, the prejowl region, and the supraperiosteal planes over the malar eminence tend to retain volume reliably.
The lips are the classic underperformer. They are highly mobile, they are thin, and constant motion disrupts early neovascularization. Fat grafting to the lips can work beautifully, but it should be undertaken with a frank expectation of lower retention and a possible second pass. Some surgeons prefer a structural approach such as a lip lift for shape and a modest fat graft for substance rather than asking fat to do the entire job.
The lower eyelid and tear trough are the highest stakes region on the face. The skin is the thinnest anywhere on the body, the orbicularis is in continuous motion, and the margin for irregularity is close to zero. Over grafting here produces persistent puffiness that is genuinely difficult to correct. Many surgeons deliberately undercorrect the tear trough and stage it, or treat the region with a combination of deep malar support and conservative superficial work rather than direct heavy filling. For patients whose concern is confined to that region, targeted tear trough rejuvenation may be a more controlled starting point than a full facial graft.
Scarred, irradiated, or previously operated tissue has compromised vascularity and takes less reliably. Areas where filler has previously been placed can be unpredictable, particularly if residual product is still present, and it is reasonable to dissolve residual filler and wait before grafting.
Why a Second Session Is Sometimes Planned From the Start
Staging is not a failure. In certain patients it is the correct plan, decided in the consultation room before the first operation.
Candidates for planned two stage grafting share recognizable features: significant volume deficit, thin skin, prior facial surgery or radiation, a very low body mass index limiting donor availability, or work in a region such as the lips or lower lids where conservative undercorrection is safer.
The logic is straightforward. A recipient bed can only support so much graft at once, because the limiting factor is diffusion distance and capillary ingrowth, not the surgeon's willingness to inject. Pushing more fat into a thin face produces more dead fat, more inflammation, a higher risk of nodules, and raised interstitial pressure that itself impairs perfusion.
The first session accomplishes two things: it restores a meaningful proportion of the deficit, and it improves the recipient bed. Grafted tissue is better vascularized and thicker than it was, which means a second session placed at six months or later enjoys better conditions than the first one did. Retention on the second pass is frequently better than the first.
Telling a patient at the outset that two sessions are likely is a sign of candor, not of uncertainty. The alternative, promising a single session and then presenting a second one as a correction, serves nobody.
Smoking, Weight Fluctuation, and Other Things That Kill Grafts
Some survival variables belong to the surgeon. Others belong entirely to the patient.
Smoking and nicotine in any form, including vaping, patches, and pouches, cause peripheral vasoconstriction and directly impair the capillary ingrowth a fat graft depends on. Nicotine is arguably the single most damaging modifiable factor in fat grafting. Four weeks of complete cessation before and after surgery is a reasonable minimum.
Weight fluctuation is the variable patients most often overlook. Transferred fat cells behave like the fat they came from. They enlarge when you gain weight and shrink when you lose it. A patient who undergoes facial fat grafting and then loses 25 pounds will lose facial volume, and will sometimes conclude the graft failed when in fact it is simply responding to the same signals as the rest of the body's adipose tissue. This has become a practical issue in the era of GLP-1 medication, where rapid weight loss reshapes the face dramatically and creates the hollowed appearance that has driven interest in restoring facial volume after GLP-1 weight loss. The sensible sequence is to reach a stable weight first, hold it, then graft.
Pressure matters too. Direct sustained pressure on freshly grafted areas in the first two weeks can compromise perfusion, which is why sleeping on the back with the head elevated is standard advice.
Poorly controlled diabetes, significant vascular disease, and systemic steroid use all impair graft take. These are among the reasons Dr. Doshi raises the case for addressing facial aging earlier rather than later.
Prejuvenation: The Argument for Not Waiting Until Sixty
The traditional model of facial surgery assumed a patient waited until the changes were undeniable, then had a large operation to reverse fifteen years at once. Dr. Doshi argues against that model.
Healing is better at fifty than at sixty five. Tissue is more elastic, the microvasculature is healthier, comorbidities are fewer, medication lists are shorter, and recovery is faster and more predictable. All of those factors bear directly on fat graft survival, because graft survival is a wound healing process.
There is also a point about arithmetic. A patient who addresses volume loss in their early fifties enjoys the result for twenty five years. A patient who waits until sixty eight enjoys it for fewer, and undergoes a bigger operation to get there.
Prejuvenation does not mean operating on young people who do not need it. It means intervening at the stage where a modest procedure achieves what a much larger one would be required to achieve later. Fat transfer fits this model well, because early volume restoration supports the overlying soft tissue and may slow the compounding effect of deflation pulling on the ligaments.
Where Fat Transfer Fits Alongside Lifting
Volume and position are separate problems, and this is the single most important conceptual distinction in facial rejuvenation.
Descent is a positional problem. The retaining ligaments relax, the SMAS layer loosens, and the fat compartments of the midface migrate downward and medially. No amount of injected volume corrects that. Filling a descended face makes it a larger descended face. The correct answer is repositioning, which is what a deep plane facelift accomplishes by releasing the retaining ligaments and moving the composite flap along a vertical vector. Patients with predominantly jawline and neck laxity may need a neck lift, and patients with early, limited descent may be appropriately served by a mini facelift.
Deflation is a volumetric problem. The deep medial cheek fat atrophies, the temporal fossa hollows, the pyriform aperture erodes, the prejowl sulcus deepens. Lifting alone does not fix deflation, and a lifted but deflated face can look tighter and simultaneously older.
Most patients over fifty have both, in different proportions, and the assessment that decides the proportion is the whole value of an in-person consultation. This is why facial fat transfer is so often performed at the same time as a lift: the lift repositions, the fat replaces. Combining them also means one anesthetic and one recovery.
Fat grafting combines readily with other procedures as well. It is frequently paired with eyelid surgery, where volume restoration at the lid cheek junction complements the removal or repositioning of herniated orbital fat. It pairs with a brow lift for the upper third. It pairs with chin augmentation when the skeletal deficiency requires more projection than soft tissue can deliver. And it is sometimes paired, counterintuitively, with buccal fat removal, because the correct answer in a face with lower cheek heaviness and upper cheek hollowing is to remove volume from one compartment and add it to another.
What Fat Transfer Does Not Do
Candor requires a list of limits.
It does not tighten skin. Fat grafting restores volume and, in the case of nano fat, improves dermal quality, but it does not lift. A patient with significant laxity who receives only fat will be disappointed.
It does not resurface. Pigmentation, deep static rhytids, and actinic damage need energy based treatment. Fractional CO2 Laser Resurfacing addresses the epidermis and papillary dermis in a way no injectable can. It combines well with grafting, though timing has to be coordinated so resurfacing does not compromise a fresh graft.
It is not a same-week procedure with no downtime. Expect meaningful swelling for two to three weeks, with residual asymmetry and firmness resolving over two to three months. The donor site is bruised and tender for a similar period.
It is not fully predictable in its final volume. This is the honest trade off against hyaluronic acid filler, which delivers an exact known quantity that can be dissolved if you dislike it. Fat offers permanence, autologous tissue, and regenerative effects that filler does not, at the cost of precision and predictability. For patients not ready for surgery, a non surgical approach using dermal fillers or a liquid facelift remains a reasonable interim step, and for those who have accumulated too much product over the years, dissolving existing filler and allowing the tissue to settle is often the necessary first move.
Consultation and Assessment on Long Island and in New York City
A useful consultation is mostly an assessment of anatomy, not a discussion of syringe counts.
The examination should evaluate skin thickness and quality, the state of each fat compartment individually rather than the face as a whole, skeletal support at the malar eminence, pyriform aperture, and mandible, and the degree of true descent as opposed to apparent descent caused by deflation. Prior filler history, weight stability, and smoking should all be discussed frankly.
Before and after photographs of patients with comparable starting anatomy are more informative than dramatic results in different faces. For patients outside the immediate Long Island and Manhattan area, a virtual consultation is a practical first step before traveling for an in-person examination.
The right surgeon will tell you how much of the fat is likely to survive in your particular face, why, which regions they expect to underperform, and whether they would plan a second session from the outset. If those answers come easily and specifically, you are in the right room.